Skip to main content

Peer Review reports

From: Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis

Original Submission
21 Aug 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Nov 2016 Editorially accepted
29 Nov 2016 Article published 10.1186/s12879-016-2056-3

You can find further information about peer review here.

Back to article page